Yung Shin Pharmaceutical Industrial Co Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MICAFUNGIN SODIUM "YUNG SHIN", with a corresponding US DMF Number 34888.
Remarkably, this DMF maintains an Active status since its submission on July 31, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 01, 2020, and payment made on August 07, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II